Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Rivaroxaban in Chronic HemodialysisClapton Dias, Kenneth Todd Moore, Joe Murphy et al.|American Journal of Nephrology|2016Cited by 132
Rivaroxaban in Chronic Hemodialysis Patients: Clarification of an Editorial ErrorClapton Dias, Kenneth Todd Moore, Joe Murphy et al.|American Journal of Nephrology|2016Cited by 0
ErratumCraig B. Langman, Jonathan A. Fridell, Danica Grujić et al.|American Journal of Nephrology|2016Cited by 0
Erratum: Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Rivaroxaban in Chronic HemodialysisClapton Dias, Kenneth Todd Moore, Judy Murphy et al.|Figshare|2017Cited by 0
Supplementary Material for: Rivaroxaban in Chronic Hemodialysis Patients: Clarification of an Editorial ErrorClapton Dias, Kenneth Todd Moore, Judy Murphy et al.|Figshare|2016Cited by 0